Unity Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	19.8	12.74	33.46	17.81	38.92	15.95	7.85	89.74
Short-Term Investments	23.4	82.06	55.17	79.89	90.02	155.74	79.21	0
Cash & Cash Equivalents	43.2	94.8	88.63	97.7	128.93	171.69	87.06	89.74
Cash Growth	-54.43%	6.96%	-9.29%	-24.23%	-24.90%	97.20%	-2.98%	-
Other Current Assets	3.4	1.74	1.88	3.17	0.55	1.28	1.82	3.67
Total Current Assets	46.61	96.54	90.5	100.87	129.49	172.97	88.88	93.41
Property, Plant & Equipment	18.06	26.87	31.23	36.14	16.64	6.24	6.96	2.25
Long-Term Investments	0.9	0.9	2.89	19.32	3.03	0	5.12	0
Other Long-Term Assets	0.13	0.05	0.09	0	2.07	2.17	1.07	0.99
Total Long-Term Assets	19.09	27.82	34.21	55.45	21.73	8.41	13.14	3.24
Total Assets	65.69	124.35	124.71	156.32	151.22	181.38	102.02	96.65
Accounts Payable	1.38	1.79	1.99	2.56	5.19	4.85	2.38	0.96
Deferred Revenue	0	0	0.22	0	0	0	0	0
Current Debt	0	9.48	4.02	0	0	0	0	0
Other Current Liabilities	6.46	8.35	10.4	11.91	12.03	11.74	5.52	2.73
Total Current Liabilities	7.84	19.62	16.62	14.46	17.22	16.58	7.9	3.69
Long-Term Debt	23.54	37.88	48.5	58.98	0	0	0	0
Other Long-Term Liabilities	5.91	10.76	0.02	0	13.3	4.1	3.28	3.4
Total Long-Term Liabilities	29.45	48.65	48.53	58.98	13.3	4.1	3.28	3.4
Total Liabilities	37.29	68.27	65.14	73.44	30.51	20.68	11.18	7.1
Total Debt	23.54	47.36	52.52	58.98	0	0	0	0
Debt Growth	-50.30%	-9.83%	-10.95%	-	-	-	-	-
Retained Earnings	-484.35	-444.49	-400.02	-339.3	-245.46	-163.28	-86.88	-42.22
Comprehensive Income	-0.02	-0.25	-0.04	0.01	0.09	-0.1	-0.1	0
Shareholders' Equity	28.4	56.08	59.57	82.88	120.71	160.69	-83.11	-41.54
Net Cash / Debt	19.66	47.44	36.1	38.72	128.93	171.69	87.06	89.74
Net Cash / Debt Growth	-58.55%	31.39%	-6.76%	-69.97%	-24.90%	97.20%	-2.98%	-
Net Cash Per Share	1.33	5.00	6.47	7.61	29.56	60.73	272.27	336.99
Working Capital	38.77	76.92	73.89	86.4	112.27	156.38	80.98	89.72
Book Value Per Share	1.92	5.91	10.67	16.29	27.67	56.84	-259.93	-155.98

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).